CAS NO 443913-73-3 Vandetanib Pharmaceutical Intermediates
Product detail
Vandetanib is a potent, oral tyrosine kinase inhibitor that targets multiple pathways involved in tumor growth and progression. It is primarily used to treat medullary thyroid carcinoma (MTC) and has shown promise in other malignancies. Vandetanib has a unique mechanism of action that inhibits the activity of vascular endothelial growth factor receptor (VEGFR), epidermal growth factor receptor (EGFR), and rearranged during transfection (RET) kinase, making it a valuable asset in the field of oncology.
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
As a factory integrating production and trading, we are proud of our commitment to quality and excellence. Our production process follows Good Manufacturing Practice (GMP), ensuring that each batch of Vandetanib meets the highest standards of purity and potency. Our state-of-the-art facilities are equipped with advanced technology, allowing us to maintain strict quality control throughout the production process.
Vandetanib represents a significant advancement in cancer treatment, providing a targeted therapy with proven efficacy. Our integrated manufacturing and trading approach ensures high-quality pharmaceutical compounds for our customers. With a focus on innovation, quality and regulatory compliance, we are committed to supporting the pharmaceutical industry in delivering effective treatments to patients around the world. Choose Vandetanib for a reliable and effective oncology solution.



